Risk Factors Associated With Quantitative Evidence of Lung Emphysema and Fibrosis in an HIV-Infected Cohort
- PMID: 26914911
- PMCID: PMC4770858
- DOI: 10.1097/QAI.0000000000000894
Risk Factors Associated With Quantitative Evidence of Lung Emphysema and Fibrosis in an HIV-Infected Cohort
Abstract
Introduction: The disease spectrum for HIV-infected individuals has shifted toward comorbid non-AIDS conditions including chronic lung disease, but quantitative image analysis of lung disease has not been performed.
Objectives: To quantify the prevalence of structural changes of the lung indicating emphysema or fibrosis on radiographic examination.
Methods: A cross-sectional analysis of 510 HIV-infected participants in the multicenter Lung-HIV study was performed. Data collected included demographics, biological markers of HIV, pulmonary function testing, and chest computed tomographic examinations. Emphysema and fibrosis-like changes were quantified on computed tomographic images based on threshold approaches.
Results: In our cohort, 69% was on antiretroviral therapy, 13% had a current CD4 cell count less than 200 cells per microliter, 39% had an HIV viral load greater than 500 copies per milliliter, and 25% had at least a trace level of emphysema (defined as >2.5% of voxels <-950HU). Trace emphysema was significantly correlated with age, smoking, and pulmonary function. Neither current CD4 cell count nor HIV viral load was significantly correlated with emphysema. Fibrosis-like changes were detected in 29% of the participants and were significantly correlated with HIV viral load (Pearson correlation coefficient = 0.210; P < 0.05); current CD4 cell count was not associated with fibrosis. In multivariable analyses including age, race, and smoking status, HIV viral load remained significantly correlated with fibrosis-like changes (coefficient = 0.107; P = 0.03).
Conclusions: A higher HIV viral load was significantly associated with fibrosis-like changes, possibly indicating early interstitial lung disease, but emphysematous changes were not related to current CD4 cell count or HIV viral load.
Conflict of interest statement
References
-
- Cohen BA, Pomeranz S, Rabinowitz JG, et al. Pulmonary complications of AIDS: radiologic features. AJR Am J Roentgenol. 1984 Jul;143(1):115–122. - PubMed
-
- Kuhlman JE, Fishman EK, Hruban RH, Knowles M, Zerhouni EA, Siegelman SS. Diseases of the chest in AIDS: CT diagnosis. Radiographics. 1989 Sep;9(5):827–857. - PubMed
-
- Murray JF, Mills J. Pulmonary infectious complications of human immunodeficiency virus infection. Part I. Am Rev Respir Dis. 1990 May;141(5 Pt 1):1356–1372. - PubMed
-
- Murray JF, Mills J. Pulmonary infectious complications of human immunodeficiency virus infection. Part II. Am Rev Respir Dis. 1990 Jun;141(6):1582–1598. - PubMed
-
- Braithwaite RS, Justice AC, Chang CC, et al. Estimating the proportion of patients infected with HIV who will die of comorbid diseases. Am J Med. 2005 Aug;118(8):890–898. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 HL121814/HL/NHLBI NIH HHS/United States
- U01 AI035042/AI/NIAID NIH HHS/United States
- U01 DA036297/DA/NIDA NIH HHS/United States
- R01-HL090316/HL/NHLBI NIH HHS/United States
- UL1 TR000005/TR/NCATS NIH HHS/United States
- U01-AI-35043/AI/NIAID NIH HHS/United States
- R01 HL090483/HL/NHLBI NIH HHS/United States
- U01-AI-35042/AI/NIAID NIH HHS/United States
- U01-AI-42590/AI/NIAID NIH HHS/United States
- UL1 RR024153/RR/NCRR NIH HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- U01 AI031834/AI/NIAID NIH HHS/United States
- R01-HL126549/HL/NHLBI NIH HHS/United States
- K24-HL087713/HL/NHLBI NIH HHS/United States
- R01-HL090339/HL/NHLBI NIH HHS/United States
- U01 AI035004/AI/NIAID NIH HHS/United States
- U01-HD-32632/HD/NICHD NIH HHS/United States
- R01 HL090342/HL/NHLBI NIH HHS/United States
- R01-HL090331/HL/NHLBI NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- U01 AI034989/AI/NIAID NIH HHS/United States
- U01-HL121814/HL/NHLBI NIH HHS/United States
- R01 HL090316/HL/NHLBI NIH HHS/United States
- UL1TR000005/TR/NCATS NIH HHS/United States
- U01-AI-35041/AI/NIAID NIH HHS/United States
- U01-AI-34994/AI/NIAID NIH HHS/United States
- U01 AI035041/AI/NIAID NIH HHS/United States
- R01-HL090342/HL/NHLBI NIH HHS/United States
- UM1 AI035043/AI/NIAID NIH HHS/United States
- U01-AI-35004/AI/NIAID NIH HHS/United States
- U01-AI-31834/AI/NIAID NIH HHS/United States
- R01 HL090331/HL/NHLBI NIH HHS/United States
- U01 AI034994/AI/NIAID NIH HHS/United States
- K24 HL087713/HL/NHLBI NIH HHS/United States
- R01 HL090313/HL/NHLBI NIH HHS/United States
- R01-HL090335/HL/NHLBI NIH HHS/United States
- UL1-RR025005/RR/NCRR NIH HHS/United States
- U01-AI-35040/AI/NIAID NIH HHS/United States
- R01 HL090339/HL/NHLBI NIH HHS/United States
- UL1TR000004/TR/NCATS NIH HHS/United States
- K24 AI118591/AI/NIAID NIH HHS/United States
- R01 HL090335/HL/NHLBI NIH HHS/United States
- U01 AI035043/AI/NIAID NIH HHS/United States
- U01-AI-34993/AI/NIAID NIH HHS/United States
- R01-HL125432/HL/NHLBI NIH HHS/United States
- R01 DA012568/DA/NIDA NIH HHS/United States
- U01-AI-35039/AI/NIAID NIH HHS/United States
- U01 AI035040/AI/NIAID NIH HHS/United States
- U01 AI034993/AI/NIAID NIH HHS/United States
- R01 HL125432/HL/NHLBI NIH HHS/United States
- UL1 TR000004/TR/NCATS NIH HHS/United States
- U01 HL121819/HL/NHLBI NIH HHS/United States
- R01-HL090313/HL/NHLBI NIH HHS/United States
- U01 AI035039/AI/NIAID NIH HHS/United States
- R01 HL126549/HL/NHLBI NIH HHS/United States
- U01-AI-34989/AI/NIAID NIH HHS/United States
- U01 HD032632/HD/NICHD NIH HHS/United States
- U01 AI042590/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
